Skip to main content
SpringerLink
Log in

AE signals for alpelisib: hyperglycaemia, mBC, liver metastases

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. the lower end of IC 95% CI

Reference

  • Chen X, et al. Adverse Events of Alpelisib: A post-marketing study of the World Health Organization pharmacovigilance database. British Journal of Clinical Pharmacology : 16 Nov 2021. Available from: URL: http://doi.org/10.1111/bcp.15143

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AE signals for alpelisib: hyperglycaemia, mBC, liver metastases. Reactions Weekly 1883, 5 (2021). https://doi.org/10.1007/s40278-021-05960-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-05960-9

Search

Navigation